Immune milk against SARS-CoV-2 virus is obtained from cows on a farm in Karakalpakstan

The International Center for Molecular Allergology under the Ministry of Innovative Development and the Medical University of Vienna, Austria are implementing a project to obtain immune milk against the SARS-CoV-2 virus.

A team of scientists from the International Center for Molecular Allergology in the field of biotechnology and comparative medicine received experimental samples from the immune milk of cows vaccinated with the ZF-UZ-VAC2001 Uzbek-Chinese vaccine.

The resulting immune milk contains antibodies against the coronavirus, which neutralize the binding of the SARS-CoV-2 virus to the APF-2 receptor in the human cell, preventing the virus from entering and multiplying in human cells. In the future, this immune milk and its products may be recommended for industrial production.

In conformity with the cooperation agreement between the International Center for Molecular Allergology and PanaevPharms FX in the Republic of Karakalpakstan, currently 31 head of Simmental cows and Holstein cows imported from Austria and Germany will be vaccinated with safe and effective ZF-UZ-VAC2001.